Ampio raises $6.6M in direct public offering

Inflammatory disease company Ampio Pharmaceuticals Inc. (NYSE-M:AMPE) raised $6.6 million through the sale of 11 million units at $0.60 in a registered direct offering on June 7. Each unit comprises ...